Current status:
Cancelled Pre Market
Current status date:
2026-01-27
Product name:
REACTINE EYE DROPS
DIN:
02237000
Electronic product monograph is not available
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Schedule(s):
NON-PRESCRIPTION DRUGS
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
List of active ingredient(s)
|
Active ingredient(s)
See footnote8
|
Strength |
|
NAPHAZOLINE HYDROCHLORIDE
|
0.025 % / W/V
|
|
PHENIRAMINE MALEATE
|
0.3 % / W/V
|
